Skip to main content
Clinical Trials/IRCT20120215009014N321
IRCT20120215009014N321
Recruiting
Phase 2

Effect of intravenous ibuprofen versus intravenous paracetamol on the occlusion of patent ductus arteriosus in preterm infants: a single-blind randomized clinical trial

Hamedan University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Patent ductus arteriosus.
Sponsor
Hamedan University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gestational age equal to or less than 37 weeks,
  • The past time after birth equal to or less than 14 days,
  • Patent ductus arteriosus

Exclusion Criteria

  • Infectious disease,
  • Hyperbilirubinemia needing transfusion,
  • Active necrotizing enterocolitis or intestinal perforation,
  • Liver function disorder,
  • Any hemorrhagic disorder,
  • Retinopathy,
  • Bronchopulmonary dysplasia,
  • Platelet deficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials